Cellular neurothekeoma
- PMID: 35028394
- PMCID: PMC8714564
- DOI: 10.1016/j.ijwd.2021.07.011
Cellular neurothekeoma
Keywords: Case report; Cellular neurothekeoma; Nerve sheath tumor.
Conflict of interest statement
Mr John Frew has conducted advisory work for Janssen, Boehringer-Ingelheim, Pfizer, Kyowa Kirin, LEO Pharms, Regeneron, and UCB; participated in trials for UCB, Pfizer, and Eli Lilly; and received research support from Ortho Dermatologics.
Figures
References
-
- Fetsch JF, Laskin WB, Hallman JR, Lupton GP, Miettinen M. Neurothekeoma: An analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information. Am J Surg Pathol. 2007;31(7):1103–1114. - PubMed
-
- Hornick JL, Fletcher CD. Cellular neurothekeoma: Detailed characterization in a series of 133 cases. Am J Surg Pathol. 2007;31(3):329–340. - PubMed
-
- Laskin WB, Fetsch JF, Miettinen M. The "neurothekeoma": Immunohistochemical analysis distinguishes the true nerve sheath myxoma from its mimics. Hum Pathol. 2000;31(10):1230–1241. - PubMed
-
- Stratton J, Billings SD. Cellular neurothekeoma: Analysis of 37 cases emphasizing atypical histologic features. Mod Pathol. 2014;27(5):701–710. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
